IPO ends decade-long pre-grant opposition to Gilead’s Sofosbuvir prodrug
In a landmark case, Gilead Pharmasset, LLC v Sankalp Rehabilitation Trust and Ors., the Indian Patent Office (IPO) in Kolkata granted a patent to Gilead Pharmasset, LLC (Gilead), covering the prodrug molecule of anti-HCV drug Sofosbuvir. The IPO rejected all the 13 pre-grant oppositions, filed by various opponents including pharma companies,...
Court assesses lung cancer drug patent infringement by the company.
/*! elementor - v3.16.0 - 17-10-2023 */
.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading...
The Creation of the Intellectual Property Division: A Milestone in India’s IP Adjudication Framework
The abolishment of the Intellectual Property Appellate Board (IPAB) through the Tribunals Reforms Act, 2021 brought about a period of uncertainty in
Read Full...
Delhi High Court to address conflicting views on Divisional applications
/*! elementor - v3.16.0 - 20-09-2023 */
.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading...